Related Experiment Video

Updated: Jul 19, 2026

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Role of metals in neuronal apoptosis: challenges associated with neurodegeneration

Bharathi1, R Ravid, K S Jagannathan Rao

  • 1Central Food Technological Research Institute, Mysore, India.

Current Alzheimer Research
|October 5, 2006
PubMed

Insights

This review explores how metals trigger apoptosis, or programmed cell death, in Alzheimer's disease. Understanding metal-induced neuronal cell death is key to neurodegeneration research.

Area of Science:

  • Neuroscience
  • Toxicology
  • Cell Biology

Background:

  • Apoptosis, a regulated cell death process, is crucial for development and disease.
  • Metal toxicity and its role in neurodegenerative diseases like Alzheimer's are significant research areas.
  • The balance of apoptotic pathways determines cell fate, making them a 'double-edged sword'.

Purpose of the Study:

  • To review current knowledge on apoptosis pathways initiated by metals in Alzheimer's disease.
  • To elucidate mechanisms of metal-induced and metal-amyloid-beta-linked neuronal cell death.
  • To highlight the role of reactive oxygen species (ROS) and metal speciation in neurodegeneration.

Main Methods:

  • Literature review focusing on apoptosis mechanisms.
  • Analysis of signaling pathways involved in metal-induced cell death.
  • Examination of the interplay between metals, amyloid-beta, and ROS in Alzheimer's disease.

Main Results:

  • Metals can directly or indirectly induce neuronal cell death via apoptosis in Alzheimer's disease.
  • Reactive oxygen species (ROS) play a critical role in mediating metal-induced neurotoxicity.
  • Metal speciation may influence the progression and mechanisms of neurodegeneration.

Conclusions:

  • Understanding metal-induced apoptosis is vital for developing therapeutic strategies for Alzheimer's disease.
  • Further research into metal speciation and ROS is needed to fully comprehend metal-induced neurodegeneration.
  • Targeting apoptotic pathways offers potential for treating metal-related neurotoxicity.

More Related Videos

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line08:23

Real-Time Impedance-based Cell Analyzer as a Tool to Delineate Molecular Pathways Involved in Neurotoxicity and Neuroprotection in a Neuronal Cell Line

Published on: August 9, 2014

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons10:36

Modeling Neuronal Death and Degeneration in Mouse Primary Cerebellar Granule Neurons

Published on: November 6, 2017

Related Concept Videos

Role of Neurotransmitters in Memory01:23

Role of Neurotransmitters in Memory

Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
 Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Neurotransmitters01:31

Neurotransmitters

Neurotransmitters are essential chemical messengers within the nervous system, facilitating the communication between neurons. These chemical messengers, varying in function and effect, are critical for sustaining various aspects of neurological health and emotional well-being.